May 13, 2020 / 12:00PM GMT
Operator
Thank you for standing by. This is the conference operator. Welcome to the Capricor Therapeutics HOPE-2 top-line 12-month data call. As a reminder, all participants are in listen only mode, and the conference is being recorded. (Operator Instructions)
I would now like to turn the conference over to AJ Bergmann. Please go ahead.
AJ Bergmann - Capricor Therapeutics, Inc. - CFO
Thank you, and good morning, everyone. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation.
These statements may include statements among other things regarding the efficacy, safety, and intended utilization of our product candidates; our future research and development plans, including anticipated conduct and timing and preclinical and clinical studies; our plans to present or report additional data; our plans regarding regulatory filings, potential regulatory developments, involving our product candidates; and our possible uses of existing cash and investment resources.
These forward
Capricor Therapeutics Inc to Discuss the Top-Line Results of the HOPE-2 Study - Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot